The COVID-19 pandemic has wreaked havoc on brick and mortar businesses. Consumers, confined to their homes, have flocked to online markets, where products offered by patent owners often compete with infringing products from...more
“Good Samaritan” companies may be exposing themselves to potential patent infringement liability when rapidly mobilizing to produce products for fighting the COVID-19 pandemic. In a previous e-alert, we discussed how these...more
The COVID-19 pandemic has led many companies to marshal their resources to produce products such as coronavirus test kits, pharmaceutical treatments, vaccines, ventilators, and personal protective equipment. The urgent need...more
As the COVID-19 pandemic unfolds, we are witnessing countless stories of courageous men and women rising up to face the challenges and obstacles of this crisis. Unfortunately, crisis also presents opportunity for unscrupulous...more
Businesses and consumers are increasingly purchasing products such as consumer electronics and auto parts online. The dominant online marketplace, of course, is Amazon.com, with nearly 50% of all online sales across all...more
The Supreme Court clarified this week in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. that the "On Sale Bar" — which prohibits patents on inventions that are sold or offered for sale before the patent application...more
1/24/2019
/ America Invents Act ,
Assignment of Inventions ,
Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc ,
Inventions ,
On-Sale Bar ,
Patent Applications ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Public Use ,
Reaffirmation ,
Reversal ,
SCOTUS ,
Section 102 ,
Third-Party Relationships